Prognostic implication of VEGF expression on patients in stage-I non-small cell lung cancer
Shiji Zhou
Abstract
Shiji Zhou
Abstract
Objective:To investigate the relationship between VEGF expression,angiogenesis and prognosis on stage-Ⅰ non-small cell lung cancer(NSCLC).Methods:The expression of VEGF,MVD marked by CD34 in NSCLC were detected in 70 stage-Ⅰ NSCLC and 30 normal lung tissues as control by immunohistochemical method.Results:High VEGF expression was seen in 41 patients,low VEGF expression was seen in 29 patients.Expression of VEGF was significantly higher in cancer tissues than that in normal lung tissues;There was significantly difference of MVD between high VEGF expresson lung cancer(36.39±19.78) and low VEGF expresson lung cancer(21.67±14.76);The 5-year survival rate in patients with high VEGF expression(40.0%) was much lower than that in patients with low VEGF expression(77.5%),and VEGF expression was a independent prognostic factor in stage-Ⅰ NSCLC(RR=3.51,P=0.007).Conclusion:Detection of VEGF expression may help to predict the prognosis of patients with stage-Ⅰ NSCLC and guide the postoperation adjuvent therapy.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective:To investigate the relationship between VEGF expression,angiogenesis and prognosis on stage-Ⅰ non-small cell lung cancer(NSCLC).Methods:The expression of VEGF,MVD marked by CD34 in NSCLC were detected in 70 stage-Ⅰ NSCLC and 30 normal lung tissues as control by immunohistochemical method.Results:High VEGF expression was seen in 41 patients,low VEGF expression was seen in 29 patients.Expression of VEGF was significantly higher in cancer tissues than that in normal lung tissues;There was significantly difference of MVD between high VEGF expresson lung cancer(36.39±19.78) and low VEGF expresson lung cancer(21.67±14.76);The 5-year survival rate in patients with high VEGF expression(40.0%) was much lower than that in patients with low VEGF expression(77.5%),and VEGF expression was a independent prognostic factor in stage-Ⅰ NSCLC(RR=3.51,P=0.007).Conclusion:Detection of VEGF expression may help to predict the prognosis of patients with stage-Ⅰ NSCLC and guide the postoperation adjuvent therapy.
Key concepts: Medicine, Lung cancer, Stage (stratigraphy), Angiogenesis, Immunohistochemistry, VEGF receptors, Oncology, CD34